2025 Speakers | Kisaco Research

Our Confirmed 2025 Speakers

We're excited to share with you our early confirmed speakers for 2025!

  • Author:

    Aaron Schacht

    CEO
    BiomEdit

    Aaron Schacht

    CEO
    BiomEdit
  • Author:

    Andrea Iucci

    CEO
    Norbrook Laboratories Ltd.

    Andrea Iucci

    CEO
    Norbrook Laboratories Ltd.
  • Author:

    Giovani Abruzzini

    CEO
    Virbac

    Giovani Abruzzini

    CEO
    Virbac
  • Author:

    Linda Rhodes

    VMD, PhD, Independent and ex-CSO
    Independent Animal Health

    Dr. Rhodes has over 30 years of accomplishments in human and animal drug discovery, development, biomedical research, and clinical veterinary medicine.

    Dr. Rhodes was educated at the University of Pennsylvania School of Veterinary Medicine (VMD) and Cornell University (PhD). She has an extensive background in physiology, veterinary medicine, and drug development, and many publications in peer-reviewed journals. Dr. Rhodes practiced clinical veterinary medicine for five years, with experience in both companion and farm animal practice. As a senior research fellow at Merck Research Laboratories for 8 years, she led pre-clinical biology evaluation of several marketed human drugs. She worked for Merial Ltd. as director of large animal development projects, leading project teams developing novel compounds for a variety of indications. In April 2001, she formed AlcheraBio, a consulting, marketing, and contract research firm specializing in developing new drugs for animals, working with biotechnology and animal health companies world-wide. AlcheraBio was acquired in 2008 by Argenta, and Dr. Rhodes served as executive vice president to transition the company when in 2011, she accepted a position as CEO of Aratana Therapeutics, a startup company developing innovative new medicines for dogs and cats. Subsequently, when the company became public she served as its Chief Scientific Officer. During her 5-year tenure, the company achieved FDA approval of three new pet therapeutics: Galliprant, Nocita and Entyce. She is currently retired and an independent consultant. She is a member of the Board of Directors of Zoetis, and serves on the Scientific Advisory Boards of the Alliance for Contraception in Dogs and Cats and the Michelson Found Animals Foundation. She founded Feather in Her Cap, a non-profit that recognizes the achievement of women in the animal health industry. She is the recipient of the Iron Paw Award.

    Linda Rhodes

    VMD, PhD, Independent and ex-CSO
    Independent Animal Health

    Dr. Rhodes has over 30 years of accomplishments in human and animal drug discovery, development, biomedical research, and clinical veterinary medicine.

    Dr. Rhodes was educated at the University of Pennsylvania School of Veterinary Medicine (VMD) and Cornell University (PhD). She has an extensive background in physiology, veterinary medicine, and drug development, and many publications in peer-reviewed journals. Dr. Rhodes practiced clinical veterinary medicine for five years, with experience in both companion and farm animal practice. As a senior research fellow at Merck Research Laboratories for 8 years, she led pre-clinical biology evaluation of several marketed human drugs. She worked for Merial Ltd. as director of large animal development projects, leading project teams developing novel compounds for a variety of indications. In April 2001, she formed AlcheraBio, a consulting, marketing, and contract research firm specializing in developing new drugs for animals, working with biotechnology and animal health companies world-wide. AlcheraBio was acquired in 2008 by Argenta, and Dr. Rhodes served as executive vice president to transition the company when in 2011, she accepted a position as CEO of Aratana Therapeutics, a startup company developing innovative new medicines for dogs and cats. Subsequently, when the company became public she served as its Chief Scientific Officer. During her 5-year tenure, the company achieved FDA approval of three new pet therapeutics: Galliprant, Nocita and Entyce. She is currently retired and an independent consultant. She is a member of the Board of Directors of Zoetis, and serves on the Scientific Advisory Boards of the Alliance for Contraception in Dogs and Cats and the Michelson Found Animals Foundation. She founded Feather in Her Cap, a non-profit that recognizes the achievement of women in the animal health industry. She is the recipient of the Iron Paw Award.

  • Author:

    Cynthia Cole

    Technical Partner
    Digitalis Ventures

    Cynthia Cole

    Technical Partner
    Digitalis Ventures
  • Author:

    Jimmy Barr

    Chief Medical Officer
    BluePearl Veterinary Hospital

    Jimmy Barr

    Chief Medical Officer
    BluePearl Veterinary Hospital
  • Author:

    Julia Stephanus

    Partner
    Borealis Ventures

    Julia Stephanus is a 30 year veteran of the veterinary pharmaceutical industry.  Currently Julia is President of Avviare, a consulting firm specializing in supporting veterinary focused start-ups. 

    Julia has been involved in the development and launch of 28 veterinary products.  She has been a senior executive in two start-up pharmaceutical companies (Aratana Therapeutics and Summit VetPharm), and held key positions at multi-nationals including Pfizer (now Zoetis) and its legacy companies.

    As Chief Commercial Officer of Aratana Julia provided the commercial leadership resulting in a successful IPO (NASDAQ:PETX), high-impact corporate branding, innovative go-to-market strategies for five therapeutics and the staffing of the inaugural commercial organization.

    As founder and CEO of Summit VetPharm, Julia developed and launched a new line of companion animal parasiticides, grew the company to a cash flow positive position with 85 employees in five years and divested the company to Ceva Animal Health in 2010.  A graduate of Indiana University, she has continued her executive training at Harvard, Columbia, University of Chicago and the Wharton School of Business.      

    Julia Stephanus

    Partner
    Borealis Ventures

    Julia Stephanus is a 30 year veteran of the veterinary pharmaceutical industry.  Currently Julia is President of Avviare, a consulting firm specializing in supporting veterinary focused start-ups. 

    Julia has been involved in the development and launch of 28 veterinary products.  She has been a senior executive in two start-up pharmaceutical companies (Aratana Therapeutics and Summit VetPharm), and held key positions at multi-nationals including Pfizer (now Zoetis) and its legacy companies.

    As Chief Commercial Officer of Aratana Julia provided the commercial leadership resulting in a successful IPO (NASDAQ:PETX), high-impact corporate branding, innovative go-to-market strategies for five therapeutics and the staffing of the inaugural commercial organization.

    As founder and CEO of Summit VetPharm, Julia developed and launched a new line of companion animal parasiticides, grew the company to a cash flow positive position with 85 employees in five years and divested the company to Ceva Animal Health in 2010.  A graduate of Indiana University, she has continued her executive training at Harvard, Columbia, University of Chicago and the Wharton School of Business.      

  • Author:

    Brett Wong

    Principal
    Anterra Capital

    Brett Wong

    Principal
    Anterra Capital
  • Author:

    Dain Clare

    Vice President
    NovaQuest Capital Management

    Dain Clare

    Vice President
    NovaQuest Capital Management
  • Author:

    Andrew McKenzie

    CEO
    Precision Livestock Technologies

    Andrew McKenzie

    CEO
    Precision Livestock Technologies
  • Author:

    Jason Scott

    Founder & Managing Partner
    525 Ventures

    Jason Scott

    Founder & Managing Partner
    525 Ventures
  • Author:

    Neal Fishman

    CTO of Data-Based Pathology
    IBM

    Neal Fishman

    CTO of Data-Based Pathology
    IBM
  • Author:

    Geoffrey Shmigelsky

    CTO
    OpenCupAI

    Geoffrey Shmigelsky

    CTO
    OpenCupAI
  • Author:

    Andrew McKenzie

    CEO
    Precision Livestock Technologies

    Andrew McKenzie

    CEO
    Precision Livestock Technologies
  • Author:

    Garth Jordan

    CEO
    American Animal Hospital Association

    Garth Jordan

    CEO
    American Animal Hospital Association
  • Author:

    Meaghan Gilhooly

    VP Veterinary Affairs
    Banfield Pet Hospitals

    Meaghan Gilhooly

    VP Veterinary Affairs
    Banfield Pet Hospitals
  • Author:

    Pawel Wielgus

    Board Member
    Bioceltix

    Pawel Wielgus

    Board Member
    Bioceltix
  • Author:

    Kristin Wuhrman

    Board of Directors
    CATalyst Council

    Kristin Wuhrman

    Board of Directors
    CATalyst Council
  • Author:

    Gerardo Bluske

    CEO & Co-Founder
    ByBug

    Gerardo Bluske

    CEO & Co-Founder
    ByBug
  • Author:

    Ashley Pochick

    VP Supplier Relations
    Inventory Ally

    Ashley Pochick

    VP Supplier Relations
    Inventory Ally
  • Author:

    Dr Christie Long

    Chief Medical Officer
    Modern Animal

    Dr Christie Long

    Chief Medical Officer
    Modern Animal
  • Author:

    Dr Eve Hanks

    Chief Executive Officer & Founder
    MI:RNA Diagnostics

    Dr Eve Hanks

    Chief Executive Officer & Founder
    MI:RNA Diagnostics
  • Author:

    Lukasz Bzdzion

    Founder & CEO
    Bioceltix

    Lukasz Bzdzion

    Founder & CEO
    Bioceltix
  • Author:

    Jeffrey Emmons

    VP Venture and Growth
    Emil Capital Partners

    Jeffrey Emmons

    VP Venture and Growth
    Emil Capital Partners
  • Author:

    Meaghan Gilhooly

    VP Veterinary Affairs
    Banfield Pet Hospitals

    Meaghan Gilhooly

    VP Veterinary Affairs
    Banfield Pet Hospitals
  • Author:

    Linda Block

    Investor
    Impactology Partners

    Linda Block

    Investor
    Impactology Partners
  • Author:

    Mathieu Glassman

    Founder & CEO
    Dr Cuddles

    Mathieu Glassman

    Founder & CEO
    Dr Cuddles
  • Author:

    Valerie Bertle

    General Partner
    Yellow Rocks Capital

    Valerie Bertle

    General Partner
    Yellow Rocks Capital
  • Author:

    Dace Graham

    Founder Managing Partner
    1731MGMT

    Dace Graham

    Founder Managing Partner
    1731MGMT
  • Author:

    Charles Tapp

    Founder & General Partner
    Vetted Capital

    Charles Tapp

    Founder & General Partner
    Vetted Capital
  • Author:

    Sam Razor

    Executive Chairman
    Parasight Systems

    Sam Razor

    Executive Chairman
    Parasight Systems